至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Plant-Based Peroral Vaccines

Science Direct. 2017; 
Rurik K.Salyaev,Natalya I.Rekoslavskaya
Products/Services Used Details Operation
Bacterial Expression … plants at a level of 0.06%–0.1% TSP, as follows: B subunit of thermolabile entherotoxin of E. coli LTB (0.01% TSP), HBsAg HBV (0.01% TSP), glycoprotein S coronavirus of transmissible … The synthesis of genetic construct was carried out by the company Genscript (USA) … Get A Quote

摘要

Data about the development of plant-made peroral vaccines are stated on the base of transgenic plants. Different aspects of plant made vaccines (PMV) with their peculiarities and with a plethora of advantages are discussed, in comparison with traditional vaccines. The results disclosing the characteristics of the creation of PMV of both preventive and therapeutic actions are presented. The role of regulatory genes in the increase of the production of antigenic proteins, and in the activation of the glycosylation that enhances the efficiency of PMV, is discussed, according to preventive and therapeutic vaccines and plantibodies.

关键词

peroral plant-made vaccinesmucosal immunogenic responseglycosylationhuman papillomavirus